↓ Skip to main content

Herbal therapy: a new pathway for the treatment of Alzheimer's disease

Overview of attention for article published in Alzheimer's Research & Therapy, October 2010
Altmetric Badge

Mentioned by

twitter
2 X users

Citations

dimensions_citation
55 Dimensions

Readers on

mendeley
71 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Herbal therapy: a new pathway for the treatment of Alzheimer's disease
Published in
Alzheimer's Research & Therapy, October 2010
DOI 10.1186/alzrt54
Pubmed ID
Authors

Jinzhou Tian, Jing Shi, Xuekai Zhang, Yongyan Wang

Abstract

It has been a clinical challenge to treat Alzheimer's disease (AD). In the present commentary we discuss whether herbal therapy could be a novel treatment method for AD on the basis of results from clinical trials, and discuss the implications for potential therapy for AD pathophysiology. There is evidence to suggest that single herbs or herbal formulations may offer certain complementary cognitive benefits to the approved drugs. The current evidence supporting their use alone, however, is inconclusive or inadequate owing to many methodological limitations. Herbal mixtures may have advantages with multiple target regulation compared with the single-target antagonist in the view of traditional Chinese medicine. Several clinical trials using herbal mixtures are being conducted in China and will hopefully show promising results for treating AD in the near future.

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 71 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Malaysia 1 1%
Brazil 1 1%
Unknown 69 97%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 10 14%
Student > Master 8 11%
Lecturer 5 7%
Student > Doctoral Student 5 7%
Student > Bachelor 5 7%
Other 11 15%
Unknown 27 38%
Readers by discipline Count As %
Pharmacology, Toxicology and Pharmaceutical Science 11 15%
Medicine and Dentistry 7 10%
Agricultural and Biological Sciences 6 8%
Biochemistry, Genetics and Molecular Biology 5 7%
Psychology 3 4%
Other 11 15%
Unknown 28 39%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 14 May 2016.
All research outputs
#19,944,994
of 25,374,647 outputs
Outputs from Alzheimer's Research & Therapy
#1,380
of 1,465 outputs
Outputs of similar age
#96,699
of 108,804 outputs
Outputs of similar age from Alzheimer's Research & Therapy
#2
of 3 outputs
Altmetric has tracked 25,374,647 research outputs across all sources so far. This one is in the 18th percentile – i.e., 18% of other outputs scored the same or lower than it.
So far Altmetric has tracked 1,465 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 26.6. This one is in the 4th percentile – i.e., 4% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 108,804 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 10th percentile – i.e., 10% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 3 others from the same source and published within six weeks on either side of this one.